Risk Factors Update Summary
- The statutory Medicaid drug rebate cap was eliminated, previously set at 100%, effective January 1, 2024.
- The number of employees increased from 25 to 27, with 26 full-time employees and 1 temporary employee.
- The Inflation Reduction Act of 2022 could affect pricing pressures if approved.
- The number of employees engaged in research and development activities increased from 13 to 17.
- The implementation of the rule removing safe harbor protection for price reductions was delayed until January 1, 2026.
- The final rule rescinded the Most Favored Nation model interim final rule.
- The CCPA requirements were substantially expanded effective January 1, 2023.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1359931&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.